Skye Bioscience, Inc. - 8-K Filing

Skye Bioscience terminates CFO's services agreement and appoints CEO as principal financial officer after resignation (Items: 1.02 Termination of a Material Definitive Agreement, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 8.01 Other Matters)

SEC EDGAR ·

Tickers: $SKYE

Read the full article at SEC EDGAR

More Regulatory news